<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36144851</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>27</Volume><Issue>18</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>19</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>NMR-Based Metabolomic Analysis of Cardiac Tissues Clarifies Molecular Mechanisms of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6115</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules27186115</ELocationID><Abstract><AbstractText>Viral myocarditis (VMC), which is defined as inflammation of the myocardium with consequent myocardial injury, may develop chronic disease eventually leading to dilated cardiomyopathy (DCM). Molecular mechanisms underlying the progression from acute VMC (aVMC), to chronic VMC (cVMC) and finally to DCM, are still unclear. Here, we established mouse models of VMC and DCM with Coxsackievirus B3 infection and conducted NMR-based metabolomic analysis of aqueous metabolites extracted from cardiac tissues of three histologically classified groups including aVMC, cVMC and DCM. We showed that these three pathological groups were metabolically distinct from their normal counterparts and identified three impaired metabolic pathways shared by these pathological groups relative to normal controls, including nicotinate and nicotinamide metabolism; alanine, aspartate and glutamate metabolism; and D-glutamine and D-glutamate metabolism. We also identified two extra impaired metabolic pathways in the aVMC group, including glycine, serine and threonine metabolism; and taurine and hypotaurine metabolism Furthermore, we identified potential cardiac biomarkers for metabolically distinguishing these three pathological stages from normal controls. Our results indicate that the metabolomic analysis of cardiac tissues can provide valuable insights into the molecular mechanisms underlying the progression from acute VMC to DCM.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kong</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Jinping</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory for Chemical Biology of Fujian Province, MOE Key Laboratory of Spectrochemical Analysis &amp; Instrumentation, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory for Green Pharmaceutical Technologies and Related Equipment of Ministry of Education, College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou 310014, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Ruohan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Key Laboratory for Chemical Biology of Fujian Province, MOE Key Laboratory of Spectrochemical Analysis &amp; Instrumentation, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Caihua</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Research and Communication Center of Exercise and Health, Xiamen University of Technology, Xiamen 361024, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lili</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Weifeng</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning 530021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Donghai</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Key Laboratory for Chemical Biology of Fujian Province, MOE Key Laboratory of Spectrochemical Analysis &amp; Instrumentation, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>31971357, 81160032, 21906147</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>2018JJB140169</GrantID><Agency>Natural Science Foundation of Guangxi Province</Agency><Country /></Grant><Grant><GrantID>2018Y9100</GrantID><Agency>Joint Funds for the Innovation of Science Technology of Fujian Province</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0RH81L854J</RegistryNumber><NameOfSubstance UI="D005973">Glutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>1EQV5MLY3D</RegistryNumber><NameOfSubstance UI="D013654">Taurine</NameOfSubstance></Chemical><Chemical><RegistryNumber>25X51I8RD4</RegistryNumber><NameOfSubstance UI="D009536">Niacinamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>2679MF687A</RegistryNumber><NameOfSubstance UI="D009525">Niacin</NameOfSubstance></Chemical><Chemical><RegistryNumber>2ZD004190S</RegistryNumber><NameOfSubstance UI="D013912">Threonine</NameOfSubstance></Chemical><Chemical><RegistryNumber>30KYC7MIAI</RegistryNumber><NameOfSubstance UI="D001224">Aspartic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>3KX376GY7L</RegistryNumber><NameOfSubstance UI="D018698">Glutamic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>452VLY9402</RegistryNumber><NameOfSubstance UI="D012694">Serine</NameOfSubstance></Chemical><Chemical><RegistryNumber>OF5P57N2ZX</RegistryNumber><NameOfSubstance UI="D000409">Alanine</NameOfSubstance></Chemical><Chemical><RegistryNumber>TE7660XO1C</RegistryNumber><NameOfSubstance UI="D005998">Glycine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000409" MajorTopicYN="N">Alanine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001224" MajorTopicYN="N">Aspartic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002311" MajorTopicYN="Y">Cardiomyopathy, Dilated</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018698" MajorTopicYN="N">Glutamic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005973" MajorTopicYN="N">Glutamine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005998" MajorTopicYN="N">Glycine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009525" MajorTopicYN="Y">Niacin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009536" MajorTopicYN="N">Niacinamide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012694" MajorTopicYN="N">Serine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013654" MajorTopicYN="N">Taurine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013912" MajorTopicYN="N">Threonine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NMR</Keyword><Keyword MajorTopicYN="N">cardiac tissue</Keyword><Keyword MajorTopicYN="N">dilated cardiomyopathy</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">viral myocarditis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>9</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>23</Day><Hour>1</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36144851</ArticleId><ArticleId IdType="pmc">PMC9500976</ArticleId><ArticleId IdType="doi">10.3390/molecules27186115</ArticleId><ArticleId IdType="pii">molecules27186115</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Van Linthout S., Tschope C., Schultheiss H.P. Lack in treatment options for virus-induced inflammatory cardiomyopathy: Can iPS-derived cardiomyocytes close the gap? Circ. Res. 2014;115:540–541. doi: 10.1161/CIRCRESAHA.114.304951.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.114.304951</ArticleId><ArticleId IdType="pubmed">25170089</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman AM M.D. myocarditis. N. Engl. J. Med. 2000;343:1388–1398. doi: 10.1056/NEJM200011093431908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200011093431908</ArticleId><ArticleId IdType="pubmed">11070105</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinschen M.M., Ivanisevic J., Giera M., Siuzdak G. Identification of bioactive metabolites using activity metabolomics. Nat. Rev. Mol. Cell Biol. 2019;20:353–367. doi: 10.1038/s41580-019-0108-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0108-4</ArticleId><ArticleId IdType="pmc">PMC6613555</ArticleId><ArticleId IdType="pubmed">30814649</ArticleId></ArticleIdList></Reference><Reference><Citation>McGarrah R.W., Crown S.B., Zhang G.F., Shah S.H., Newgard C.B. Cardiovascular Metabolomics. Circ. Res. 2018;122:1238–1258. doi: 10.1161/CIRCRESAHA.117.311002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.311002</ArticleId><ArticleId IdType="pmc">PMC6029726</ArticleId><ArticleId IdType="pubmed">29700070</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui H., Chen Y., Li K., Zhan R., Zhao M., Xu Y., Lin Z., Fu Y., He Q., Tang P.C., et al. Untargeted metabolomics identifies succinate as a biomarker and therapeutic target in aortic aneurysm and dissection. Eur. Heart J. 2021;42:4373–4385. doi: 10.1093/eurheartj/ehab605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab605</ArticleId><ArticleId IdType="pubmed">34534287</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong Q., Gu J., Lu R., Huang C., Hu X., Wu W., Lin D. NMR-Based Metabolomic Analysis of Sera in Mouse Models of CVB3-Induced Viral Myocarditis and Dilated Cardiomyopathy. Biomolecules. 2022;12:112. doi: 10.3390/biom12010112.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12010112</ArticleId><ArticleId IdType="pmc">PMC8773787</ArticleId><ArticleId IdType="pubmed">35053260</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook A.A., Powers R. Quantitative NMR-Based Biomedical Metabolomics: Current Status and Applications. Molecules. 2020;25:5128. doi: 10.3390/molecules25215128.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25215128</ArticleId><ArticleId IdType="pmc">PMC7662776</ArticleId><ArticleId IdType="pubmed">33158172</ArticleId></ArticleIdList></Reference><Reference><Citation>Ampong I. Metabolic and Metabolomics Insights into Dilated Cardiomyopathy. Ann. Nutr. Metab. 2022;78:147–155. doi: 10.1159/000524722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000524722</ArticleId><ArticleId IdType="pubmed">35472668</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas J., Frese K.S., Sedaghat-Hamedani F., Kayvanpour E., Tappu R., Nietsch R., Tugrul O.F., Wisdom M., Dietrich C., Amr A., et al. Energy Metabolites as Biomarkers in Ischemic and Dilated Cardiomyopathy. Int. J. Mol. Sci. 2021;22:1999. doi: 10.3390/ijms22041999.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22041999</ArticleId><ArticleId IdType="pmc">PMC7923201</ArticleId><ArticleId IdType="pubmed">33670449</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J., Yang S., Jing R., Jin H., Hu Y., Wang J., Gu M., Niu H., Zhang S., Chen L., et al. Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy. Front. Cardiovasc. Med. 2020;7:597546. doi: 10.3389/fcvm.2020.597546.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.597546</ArticleId><ArticleId IdType="pmc">PMC7683512</ArticleId><ArticleId IdType="pubmed">33240942</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson C.H., Ivanisevic J., Siuzdak G. Metabolomics: Beyond biomarkers and towards mechanisms. Nat. Rev. Mol. Cell Biol. 2016;17:451–459. doi: 10.1038/nrm.2016.25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2016.25</ArticleId><ArticleId IdType="pmc">PMC5729912</ArticleId><ArticleId IdType="pubmed">26979502</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin JL N.A. Metabolomics as a functional genomic tool for understanding lipid dysfunction in diabetes, obesity and related disorders. Pharmacogenomics. 2006;7:1095–1107. doi: 10.2217/14622416.7.7.1095.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/14622416.7.7.1095</ArticleId><ArticleId IdType="pubmed">17054419</ArticleId></ArticleIdList></Reference><Reference><Citation>Song H., Wang L., Liu H.L., Wu X.B., Wang H.S., Liu Z.H., Li Y., Diao D.C., Chen H.L., Peng J.S. Tissue metabolomic fingerprinting reveals metabolic disorders associated with human gastric cancer morbidity. Oncol. Rep. 2011;26:431–438. doi: 10.3892/or.2011.1302.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/or.2011.1302</ArticleId><ArticleId IdType="pubmed">21567103</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreekumar A., Poisson L.M., Rajendiran T.M., Khan A.P., Cao Q., Yu J., Laxman B., Mehra R., Lonigro R.J., Li Y., et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009;457:910–914. doi: 10.1038/nature07762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07762</ArticleId><ArticleId IdType="pmc">PMC2724746</ArticleId><ArticleId IdType="pubmed">19212411</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam P.E. Coxsackievirus myocarditis: Interplay between virus and host in the pathogenesis of heart disease. Viral Immunol. 2006;19:133–146. doi: 10.1089/vim.2006.19.133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2006.19.133</ArticleId><ArticleId IdType="pubmed">16817756</ArticleId></ArticleIdList></Reference><Reference><Citation>Masui R., Sasaki M., Funaki Y., Ogasawara N., Mizuno M., Iida A., Izawa S., Kondo Y., Ito Y., Tamura Y., et al. G protein-coupled receptor 43 moderates gut inflammation through cytokine regulation from mononuclear cells. Inflamm. Bowel Dis. 2013;19:2848–2856. doi: 10.1097/01.MIB.0000435444.14860.ea.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.MIB.0000435444.14860.ea</ArticleId><ArticleId IdType="pubmed">24141712</ArticleId></ArticleIdList></Reference><Reference><Citation>Pirozzi C., Francisco V., Guida F.D., Gomez R., Lago F., Pino J., Meli R., Gualillo O. Butyrate Modulates Inflammation in Chondrocytes via GPR43 Receptor. Cell. Physiol. Biochem. 2018;51:228–243. doi: 10.1159/000495203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000495203</ArticleId><ArticleId IdType="pubmed">30448827</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakajima A., Nakatani A., Hasegawa S., Irie J., Ozawa K., Tsujimoto G., Suganami T., Itoh H., Kimura I. The short chain fatty acid receptor GPR43 regulates inflammatory signals in adipose tissue M2-type macrophages. PLoS ONE. 2017;12:e0179696. doi: 10.1371/journal.pone.0179696.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179696</ArticleId><ArticleId IdType="pmc">PMC5503175</ArticleId><ArticleId IdType="pubmed">28692672</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K., Matoba A., Shibata S., Masaki E., Emala C.W., Sr. Obesity-induced asthma: Role of free fatty acid receptors. Jpn. Dent. Sci. Rev. 2019;55:103–107. doi: 10.1016/j.jdsr.2019.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdsr.2019.07.002</ArticleId><ArticleId IdType="pmc">PMC6728269</ArticleId><ArticleId IdType="pubmed">31516639</ArticleId></ArticleIdList></Reference><Reference><Citation>Zambell K.L., Fitch M.D., Fleming S.E. Acetate and butyrate are the major substrates for de novo lipogenesis in rat colonic epithelial cells. J. Nutr. 2003;133:3509–3515. doi: 10.1093/jn/133.11.3509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jn/133.11.3509</ArticleId><ArticleId IdType="pubmed">14608066</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarty M.F., O’Keefe J.H., DiNicolantonio J.J. Dietary Glycine Is Rate-Limiting for Glutathione Synthesis and May Have Broad Potential for Health Protection. Ochsner J. 2018;18:81–87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5855430</ArticleId><ArticleId IdType="pubmed">29559876</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji Y., Fan X., Zhang Y., Li J., Dai Z., Wu Z. Glycine regulates mucosal immunity and the intestinal microbial composition in weaned piglets. Amino Acids. 2022;54:385–398. doi: 10.1007/s00726-021-02976-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-021-02976-y</ArticleId><ArticleId IdType="pubmed">33839961</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz M., Maldonado-Bernal C., Mondragon-Gonzalez R., Sanchez-Barrera R., Wacher N.H., Carvajal-Sandoval G., Kumate J. Glycine treatment decreases proinflammatory cytokines and increases interferon-gamma in patients with type 2 diabetes. J. Endocrinol. Investig. 2008;31:694–699. doi: 10.1007/BF03346417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03346417</ArticleId><ArticleId IdType="pubmed">18852529</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa O.M.S., Lopes N.N.F., Alves M.T.S., Caran E.M.M. Effects of Glycine on Collagen, PDGF, and EGF Expression in Model of Oral Mucositis. Nutrients. 2018;10:1485. doi: 10.3390/nu10101485.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10101485</ArticleId><ArticleId IdType="pmc">PMC6213743</ArticleId><ArticleId IdType="pubmed">30322002</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivakumar R., Babu P.V., Shyamaladevi C.S. Aspartate and glutamate prevents isoproterenol-induced cardiac toxicity by alleviating oxidative stress in rats. Exp. Toxicol. Pathol. 2011;63:137–142. doi: 10.1016/j.etp.2009.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.etp.2009.10.008</ArticleId><ArticleId IdType="pubmed">19962869</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrocco A., Frawley K., Pearce L.L., Peterson J., O’Brien J.P., Mullett S.J., Wendell S.G., St Croix C.M., Mischler S.E., Ortiz L.A. Metabolic Adaptation of Macrophages as Mechanism of Defense against Crystalline Silica. J. Immunol. 2021;207:1627–1640. doi: 10.4049/jimmunol.2000628.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2000628</ArticleId><ArticleId IdType="pmc">PMC8428747</ArticleId><ArticleId IdType="pubmed">34433619</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X., Gao Y., Liu L., Guo Y., Wang J., Ma H., Zhao R., Li B., Du Y., Yang Q. Artemisinin Alleviates Intestinal Inflammation and Metabolic Disturbance in Ulcerative Colitis Rats Induced by DSS. Evid. Based Complement. Altern. Med. 2022;2022:6211215. doi: 10.1155/2022/6211215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/6211215</ArticleId><ArticleId IdType="pmc">PMC9042626</ArticleId><ArticleId IdType="pubmed">35497913</ArticleId></ArticleIdList></Reference><Reference><Citation>Diguet N., Trammell S.A., Tannous C., Deloux R., Piquereau J., Mougenot N., Gouge A., Gressette M., Manoury B., Blanc J., et al. Nicotinamide Riboside Preserves Cardiac Function in a Mouse Model of Dilated Cardiomyopathy. Circulation. 2018;137:2256–2273. doi: 10.1161/CIRCULATIONAHA.116.026099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.026099</ArticleId><ArticleId IdType="pmc">PMC6954688</ArticleId><ArticleId IdType="pubmed">29217642</ArticleId></ArticleIdList></Reference><Reference><Citation>Canto C., Menzies K.J., Auwerx J. NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metab. 2015;22:31–53. doi: 10.1016/j.cmet.2015.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2015.05.023</ArticleId><ArticleId IdType="pmc">PMC4487780</ArticleId><ArticleId IdType="pubmed">26118927</ArticleId></ArticleIdList></Reference><Reference><Citation>Galli U., Travelli C., Massarotti A., Fakhfouri G., Rahimian R., Tron G.C., Genazzani A.A. Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. J. Med. Chem. 2013;56:6279–6296. doi: 10.1021/jm4001049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm4001049</ArticleId><ArticleId IdType="pubmed">23679915</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu C.P., Yamamoto T., Oka S., Sadoshima J. The function of nicotinamide phosphoribosyltransferase in the heart. DNA Repair. 2014;23:64–68. doi: 10.1016/j.dnarep.2014.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dnarep.2014.08.005</ArticleId><ArticleId IdType="pmc">PMC4254158</ArticleId><ArticleId IdType="pubmed">25277684</ArticleId></ArticleIdList></Reference><Reference><Citation>Murashige D., Jang C., Neinast M., Edwards J.J., Cowan A., Hyman M.C., Rabinowitz J.D., Frankel D.S., Arany Z. Comprehensive quantification of fuel use by the failing and nonfailing human heart. Science. 2020;370:364–368. doi: 10.1126/science.abc8861.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8861</ArticleId><ArticleId IdType="pmc">PMC7871704</ArticleId><ArticleId IdType="pubmed">33060364</ArticleId></ArticleIdList></Reference><Reference><Citation>Neinast M., Murashige D., Arany Z. Branched Chain Amino Acids. Annu. Rev. Physiol. 2019;81:139–164. doi: 10.1146/annurev-physiol-020518-114455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-020518-114455</ArticleId><ArticleId IdType="pmc">PMC6536377</ArticleId><ArticleId IdType="pubmed">30485760</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H., Olson K.C., Gao C., Prosdocimo D.A., Zhou M., Wang Z., Jeyaraj D., Youn J.Y., Ren S., Liu Y., et al. Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure. Circulation. 2016;133:2038–2049. doi: 10.1161/CIRCULATIONAHA.115.020226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.020226</ArticleId><ArticleId IdType="pmc">PMC4879058</ArticleId><ArticleId IdType="pubmed">27059949</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin A.M., Sheau Chin L., Teh C.H., Mostafa H., Mohamed Noor D.A., Abdul Kader M., Kah Hay Y., Ibrahim B. Pharmacometabolomics analysis of plasma to phenotype clopidogrel high on treatment platelets reactivity in coronary artery disease patients. Eur. J. Pharm. Sci. 2018;117:351–361. doi: 10.1016/j.ejps.2018.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejps.2018.03.011</ArticleId><ArticleId IdType="pubmed">29526765</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Ge J., Li H. Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease. Nat. Rev. Cardiol. 2020;17:96–115. doi: 10.1038/s41569-019-0235-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-019-0235-9</ArticleId><ArticleId IdType="pubmed">31350538</ArticleId></ArticleIdList></Reference><Reference><Citation>McMaster W.G., Kirabo A., Madhur M.S., Harrison D.G. Inflammation, immunity, and hypertensive end-organ damage. Circ. Res. 2015;116:1022–1033. doi: 10.1161/CIRCRESAHA.116.303697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.303697</ArticleId><ArticleId IdType="pmc">PMC4535695</ArticleId><ArticleId IdType="pubmed">25767287</ArticleId></ArticleIdList></Reference><Reference><Citation>Gizak A., McCubrey J.A., Rakus D. Cell-to-cell lactate shuttle operates in heart and is important in age-related heart failure. Aging. 2020;12:3388–3406. doi: 10.18632/aging.102818.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102818</ArticleId><ArticleId IdType="pmc">PMC7066931</ArticleId><ArticleId IdType="pubmed">32035422</ArticleId></ArticleIdList></Reference><Reference><Citation>GA B. Lactate shuttles in nature. Biochem. Soc. Trans. 2002;30:258–264.</Citation><ArticleIdList><ArticleId IdType="pubmed">12023861</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada Y.J., Batra J., Kochav S.M., Patel P., Jung J., Maurer M.S., Hasegawa K., Reilly M.P., Fifer M.A. Difference in Metabolomic Response to Exercise between Patients with and without Hypertrophic Cardiomyopathy. J. Cardiovasc. Transl. Res. 2021;14:246–255. doi: 10.1007/s12265-020-10051-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12265-020-10051-2</ArticleId><ArticleId IdType="pubmed">32594362</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai Q., Yuan G.Y., Wang H., Liu Z.L., Kou J.P., Yu B.Y., Li F. Exploring the protective effects of schizandrol A in acute myocardial ischemia mice by comprehensive metabolomics profiling integrated with molecular mechanism studies. Acta Pharmacol. Sin. 2020;41:1058–1072. doi: 10.1038/s41401-020-0377-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41401-020-0377-7</ArticleId><ArticleId IdType="pmc">PMC7471477</ArticleId><ArticleId IdType="pubmed">32123298</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.K., Zaidi S.H., Liu P., Dawood F., Cheah A.Y.L., Wen W.H., Saiki Y., Rabinovitch M. A serine elastase inhibitor reduces inflammation and fibrosis and preserves cardiac function after experimentally-induced murine myocarditis. Nat. Med. 1998;4:1383–1391. doi: 10.1038/3973.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/3973</ArticleId><ArticleId IdType="pubmed">9846575</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu M., Xue R.Q., Lu Y., Yong S.Y., Wu Q., Cui Y.L., Zuo X.T., Yu X.J., Zhao M., Zang W.J. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway. Cardiovasc. Res. 2019;115:530–545. doi: 10.1093/cvr/cvy217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvy217</ArticleId><ArticleId IdType="pubmed">30165480</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuboly E., Gaspar R., Ibor M.O., Gomori K., Kiss B., Strifler G., Hartmann P., Ferdinandy P., Bartekova M., Boros M., et al. L-Alpha-glycerylphosphorylcholine can be cytoprotective or cytotoxic in neonatal rat cardiac myocytes: A double-edged sword phenomenon. Mol. Cell Biochem. 2019;460:195–203. doi: 10.1007/s11010-019-03580-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-019-03580-1</ArticleId><ArticleId IdType="pmc">PMC6745025</ArticleId><ArticleId IdType="pubmed">31280435</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajardo V.M., Feng I., Chen B.Y., Perez-Ramirez C.A., Shi B., Clark P., Tian R., Lien C.L., Pellegrini M., Christofk H., et al. GLUT1 overexpression enhances glucose metabolism and promotes neonatal heart regeneration. Sci. Rep. 2021;11:8669. doi: 10.1038/s41598-021-88159-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-88159-x</ArticleId><ArticleId IdType="pmc">PMC8060418</ArticleId><ArticleId IdType="pubmed">33883682</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi M., Ellingsen O., Bathen T.F., Hoydal M.A., Stolen T., Esmaeili M. The Effect of Exercise Training on Myocardial and Skeletal Muscle Metabolism by MR Spectroscopy in Rats with Heart Failure. Metabolites. 2019;9:53. doi: 10.3390/metabo9030053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo9030053</ArticleId><ArticleId IdType="pmc">PMC6468534</ArticleId><ArticleId IdType="pubmed">30893827</ArticleId></ArticleIdList></Reference><Reference><Citation>Soukoulis V., Dihu J.B., Sole M., Anker S.D., Cleland J., Fonarow G.C., Metra M., Pasini E., Strzelczyk T., Taegtmeyer H., et al. Micronutrient deficiencies an unmet need in heart failure. J. Am. Coll. Cardiol. 2009;54:1660–1673. doi: 10.1016/j.jacc.2009.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2009.08.012</ArticleId><ArticleId IdType="pubmed">19850206</ArticleId></ArticleIdList></Reference><Reference><Citation>Doliba N.M., Babsky A.M., Doliba N.M., Wehrli S.L., Osbakken M.D. AMP promotes oxygen consumption and ATP synthesis in heart mitochondria through the adenylate kinase reaction: An NMR spectroscopy and polarography study. Cell Biochem. Funct. 2015;33:67–72. doi: 10.1002/cbf.3089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbf.3089</ArticleId><ArticleId IdType="pubmed">25663655</ArticleId></ArticleIdList></Reference><Reference><Citation>Girones N., Carbajosa S., Guerrero N.A., Poveda C., Chillon-Marinas C., Fresno M. Global metabolomic profiling of acute myocarditis caused by Trypanosoma cruzi infection. PLoS Negl. Trop. Dis. 2014;8:e3337. doi: 10.1371/journal.pntd.0003337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003337</ArticleId><ArticleId IdType="pmc">PMC4239010</ArticleId><ArticleId IdType="pubmed">25412247</ArticleId></ArticleIdList></Reference><Reference><Citation>Klawitter J., Klawitter J., Agardi E., Corby K., Leibfritz D., Lowes B.D., Christians U., Seres T. Association of DJ-1/PTEN/AKT- and ASK1/p38-mediated cell signalling with ischaemic cardiomyopathy. Cardiovasc. Res. 2013;97:66–76. doi: 10.1093/cvr/cvs302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvs302</ArticleId><ArticleId IdType="pubmed">23015639</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Li R., Liu Y., Li Z., Sun Y., Yin P., Huang R. Characteristics of Blood Metabolic Profile in Coronary Heart Disease, Dilated Cardiomyopathy and Valvular Heart Disease Induced Heart Failure. Front. Cardiovasc. Med. 2020;7:622236. doi: 10.3389/fcvm.2020.622236.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2020.622236</ArticleId><ArticleId IdType="pmc">PMC7856915</ArticleId><ArticleId IdType="pubmed">33553267</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander D., Lombardi R., Rodriguez G., Mitchell M.M., Marian A.J. Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy. Eur. J. Clin. Investig. 2011;41:527–538. doi: 10.1111/j.1365-2362.2010.02441.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.2010.02441.x</ArticleId><ArticleId IdType="pmc">PMC3071865</ArticleId><ArticleId IdType="pubmed">21155767</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D., Rose N.R. Coxsackievirus-induced myocarditis in mice: A model of autoimmune disease for studying immunotoxicity. Methods. 2007;41:118–122. doi: 10.1016/j.ymeth.2006.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2006.07.009</ArticleId><ArticleId IdType="pmc">PMC1764911</ArticleId><ArticleId IdType="pubmed">17161308</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P., Xie Y., Shen E., Li G.G., Yu Y., Zhang C.B., Yang Y., Zou Y., Ge J., Chen R., et al. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-beta1 signaling in coxsackievirus B3-induced cardiomyopathy. Eur. J. Pharmacol. 2011;658:168–174. doi: 10.1016/j.ejphar.2011.02.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2011.02.040</ArticleId><ArticleId IdType="pubmed">21371462</ArticleId></ArticleIdList></Reference><Reference><Citation>Eriksson U., Ricci R., Hunziker L., Kurrer M.O., Oudit G.Y., Watts T.H., Sonderegger I., Bachmaier K., Kopf M., Penninger J.M. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 2003;9:1484–1490. doi: 10.1038/nm960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm960</ArticleId><ArticleId IdType="pubmed">14625544</ArticleId></ArticleIdList></Reference><Reference><Citation>Querejeta R., Varo N., Lopez B., Larman M., Artinano E., Etayo J.C., Martinez Ubago J.L., Gutierrez-Stampa M., Emparanza J.I., Gil M.J., et al. Serum carboxy-terminal propeptide of procollagen type I is a marker of myocardial fibrosis in hypertensive heart disease. Circulation. 2000;101:1729–1735. doi: 10.1161/01.CIR.101.14.1729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.101.14.1729</ArticleId><ArticleId IdType="pubmed">10758057</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckonert O., Keun H.C., Ebbels T.M., Bundy J., Holmes E., Lindon J.C., Nicholson J.K. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2007;2:2692–2703. doi: 10.1038/nprot.2007.376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2007.376</ArticleId><ArticleId IdType="pubmed">18007604</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>